IMP
Process View
vitamin d metabolic process
The chemical reactions and pathways involving vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3).
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "vitamin d metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 1.000 | Human | |
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 1.000 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 1.000 | Human | |
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 1.000 | Human | |
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 1.000 | Human | |
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.999 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.988 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.970 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.928 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.861 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.748 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.647 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.531 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.380 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.350 | ||
| JUB | jub, ajuba homolog (Xenopus laevis) | 0.153 | ||
| RXRA | retinoid X receptor, alpha | 0.140 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.108 | ||
| IL1B | interleukin 1, beta | 0.085 | ||
| HR | hairless homolog (mouse) | 0.076 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.070 | ||
| NOTCH1 | notch 1 | 0.061 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.051 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.049 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.043 | Human | |
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.029 | Human | |
| TRADD | TNFRSF1A-associated via death domain | 0.025 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.023 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.023 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.022 | ||
| RUNX1 | runt-related transcription factor 1 | 0.021 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.021 | Human | |
| CCL20 | chemokine (C-C motif) ligand 20 | 0.021 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.020 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.019 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.017 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.016 | ||
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.015 | ||
| BTRC | beta-transducin repeat containing | 0.013 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.012 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.010 |